| |
| |
|
| Insider
Information: |
Grigoriadis Dimitri E. |
| Relationship: |
Chief Research Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
82,273 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,471,324 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
82,273 |
|
|
| Total
Value |
$11,471,324 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Research Officer |
2021-10-07 |
82,273 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
102 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2019-11-18 |
4 |
AS |
$115.98 |
$579,900 |
D/D |
(5,000) |
108,408 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-02-05 |
4 |
AS |
$103.15 |
$166,894 |
D/D |
(1,618) |
109,865 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-02-06 |
4 |
AS |
$101.44 |
$81,456 |
D/D |
(803) |
110,587 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-02-07 |
4 |
AS |
$103.31 |
$125,833 |
D/D |
(1,218) |
111,682 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-04-24 |
4 |
AS |
$99.41 |
$192,258 |
D/D |
(1,934) |
113,423 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-05-07 |
4 |
AS |
$105.44 |
$915,454 |
D/D |
(8,682) |
104,741 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-05-18 |
4 |
OE |
$35.99 |
$359,900 |
D/D |
10,000 |
114,741 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-05-18 |
4 |
AS |
$119.98 |
$1,199,800 |
D/D |
(10,000) |
104,741 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-05-19 |
4 |
OE |
$35.99 |
$359,900 |
D/D |
10,000 |
114,741 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-05-19 |
4 |
AS |
$125.98 |
$5,409,933 |
D/D |
(42,749) |
71,992 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-06-11 |
4 |
OE |
$32.99 |
$199,976 |
D/D |
5,571 |
77,563 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-08-05 |
4 |
AS |
$118.83 |
$268,200 |
D/D |
(2,257) |
79,593 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2020-11-12 |
4 |
AS |
$90.73 |
$204,784 |
D/D |
(2,257) |
81,624 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2021-02-05 |
4 |
AS |
$113.76 |
$68,823 |
D/D |
(605) |
82,169 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2021-02-08 |
4 |
AS |
$116.67 |
$315,999 |
D/D |
(2,708) |
85,273 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2021-10-07 |
4 |
OE |
$43.24 |
$216,200 |
D/D |
5,000 |
87,273 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Research Officer |
• – – |
2021-10-07 |
4 |
AS |
$104.75 |
$838,510 |
D/D |
(8,000) |
82,273 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President, Research |
• – – |
2008-02-05 |
4 |
AS |
$5.31 |
$6,399 |
D/D |
(1,206) |
6,485 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President, Research |
• – – |
2008-05-13 |
4 |
S |
$5.05 |
$32,749 |
D/D |
(6,485) |
0 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President, Research |
• – – |
2008-09-29 |
4 |
AS |
$4.71 |
$14,196 |
D/D |
(3,017) |
5,316 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President, Research |
• – – |
2009-01-05 |
4 |
AS |
$3.40 |
$4,976 |
D/D |
(1,462) |
7,187 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President, Research |
• – – |
2009-03-30 |
4 |
AS |
$3.43 |
$43,231 |
D/D |
(12,606) |
27,914 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President, Research |
• – – |
2009-09-28 |
4 |
AS |
$3.12 |
$9,465 |
D/D |
(3,038) |
33,210 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President, Research |
• – – |
2010-01-04 |
4 |
AS |
$2.67 |
$4,015 |
D/D |
(1,503) |
35,041 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President, Research |
• – – |
2010-03-01 |
4 |
AS |
$2.53 |
$35,315 |
D/D |
(13,955) |
54,419 |
0 |
- |
|
102 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
